Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Non Operating Investment Income (2016 - 2022)

Marimed (MRMD) has disclosed Non Operating Investment Income for 7 consecutive years, with $48000.0 as the latest value for Q1 2022.

  • On a quarterly basis, Non Operating Investment Income rose 206.67% to $48000.0 in Q1 2022 year-over-year; TTM through Mar 2022 was -$1.0 million, a 446.69% decrease, with the full-year FY2021 number at -$1.1 million, down 216.5% from a year prior.
  • Non Operating Investment Income was $48000.0 for Q1 2022 at Marimed, up from -$169368.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $354534.0 in Q4 2020 to a low of -$687002.0 in Q1 2020.
  • A 3-year average of -$156470.1 and a median of -$169368.0 in 2021 define the central range for Non Operating Investment Income.
  • Peak YoY movement for Non Operating Investment Income: tumbled 340.19% in 2021, then skyrocketed 206.67% in 2022.
  • Marimed's Non Operating Investment Income stood at $354534.0 in 2020, then crashed by 147.77% to -$169368.0 in 2021, then skyrocketed by 128.34% to $48000.0 in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Non Operating Investment Income are $48000.0 (Q1 2022), -$169368.0 (Q4 2021), and -$522106.0 (Q3 2021).